P02-42 Bioavailability of Pegvisomant 30mg/mL formulation compared to 15mg/mL Formulation: Pharmacokinetics, safety, and tolerability in healthy subjects

✍ Scribed by Jen, J.; Camacho-Hubner, C.; LaBadie, R.; Liang, Y.; Crownover, P.; Gao, X.; Hey-Hadavi, J.

• Book ID: 122491850
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 116 KB
• Volume: 22
• Category: Article
• ISSN: 1096-6374
• DOI: 10.1016/S1096-6374(12)60171-3